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All eukaryotic and prokaryotic organisms are
thought to synthesize fatty acids using a type I
or type II synthase. In addition, eukaryotes ex-
tend pre-existing long chain fatty acids using
microsomal elongases (ELOs). We have found
that Trypanosoma brucei, a eukaryotic human
parasite that causes sleeping sickness, uses
three elongases instead of type I or type II syn-
thases for the synthesis of nearly all its fatty
acids. Trypanosomes encounter diverse envi-
ronments during their life cycle with different
fatty acid requirements. The tsetse vector form
requires synthesis of stearate (C18), whereas
the bloodstream form needs myristate (C14).
We find that trypanosome fatty acid synthesis
is modular, with ELO1 converting C4 to C10,
ELO2 extending C10 to C14, and ELO3 elongat-
ing C14 to C18. In blood, ELO3 downregulation
favors myristate synthesis, whereas low con-
centrations of exogenous fatty acids in cultured
parasites cause upregulation of the entire path-
way, allowing the parasite to adapt to different
environments.
INTRODUCTION
Trypanosoma brucei, the sleeping sickness parasite, di-
vides its life cycle between the tsetse fly vector and the
mammalian host. The bloodstream form (BSF) evades
the host’s immune response by switching surface coats
composed of 107 variant surface glycoprotein (VSG) mol-
ecules (Donelson, 2003). Each VSG is tethered to the
plasmamembrane by a glycosylphosphatidylinositol (GPI)
anchor whose fatty acids (FAs) are exclusively myristate
(tetradecanoate), a 14-carbon saturated FA (Ferguson
and Cross, 1984). Myristate, via myristoyl-CoA, is incor-
porated into the GPI precursor in a microsomal FA re-
modeling reaction that replaces other long chain FAs
with myristate (Masterson et al., 1990). In contrast, tsetse
fly procyclic forms (PCFs) do not myristoylate the GPI
anchors of their surface glycoproteins (Field et al., 1991).BSF trypanosomes need massive quantities of myris-
tate for their GPI anchors. It was long believed that they
were unable to synthesize FAs de novo (Dixon et al.,
1971) and that they acquired all FAs, including myristate,
from the host blood. Although trypanosomes salvage
myristate efficiently (Doering et al., 1993), the myristate
concentration in blood is hardly adequate to support GPI
myristoylation at high parasite densities (Paul et al., 2001).
Several years ago we questioned whether trypanosomes
synthesize FAs and discovered that indeed they do (Mor-
ita et al., 2000). We developed a cell-free system for FA
synthesis containing trypanosome membranes (a source
of enzymes), butyryl-CoA (the four-carbon primer; ace-
tyl-CoA does not prime), malonyl-CoA (the two-carbon
donor), and NADPH. The end product with BSF mem-
branes is predominantly myristate, which can be used
for GPI anchors. In contrast, the longest end product in
PCFs is stearate (octadecanoate; C18).
In other cell types, FAs are made by a type I or type II FA
synthase (Smith, 1994; White et al., 2005). Type I en-
zymes, found in the cytosol of mammals and fungi, have
multiple catalytic activities residing on separate domains
of one or two large polypeptides (Smith, 1994). An excep-
tion is found inMusca domestica and Blattella germanica.
In addition to a cytosolic type I FA synthase, both insects
utilize a type I FA synthase that is a microsomal peripheral
membrane protein in the integument to produce methyl-
branched FAs (Juarez et al., 1992; Gu et al., 1997). Type
II FA synthases, also soluble and found in bacteria, plants,
and in eukaryotic organelles of prokaryotic origin, have
similar catalytic activities, but each is on a separate poly-
peptide (White et al., 2005; Zhang et al., 2005). In both sys-
tems the growing chain is esterified to acyl-carrier protein
(ACP) or an ACP-like domain.
So which system makes FAs in T. brucei? The T. brucei
genome does not encode a type I FA synthase, but does
predict a type II system (Paul et al., 2001). Thus, we natu-
rally assumed that the synthasewas type II. However, sev-
eral observations taken together suggested the type II
pathway is not responsible for trypanosome bulk FA syn-
thesis. First, typical type II systems are composed of sol-
uble proteins, yet the trypanosome activity is membrane-
associated. Second, type II enzymes and ACP localize to
the trypanosome’s single mitochondrion (J.S., unpub-
lished data), but the myristate product is needed in theCell 126, 691–699, August 25, 2006 ª2006 Elsevier Inc. 691
ERwhere GPI remodeling occurs. Third, triclosan, a type II
enoyl-ACP reductase inhibitor, affects cell-free FA synthe-
sis only at high concentrations, suggesting nonspecific in-
hibition (Paul et al., 2004). Fourth, cerulenin, which inhibits
the b-ketoacyl-ACP synthase (KAS; both type I and type
II), does not affect cell-free synthesis of intermediates up
to C10, although it does inhibit extension beyond C10
(Morita et al., 2000). This specificity of cerulenin could
be explained by the existence of two KAS activities; how-
ever, the genome predicts only one. Finally, and most
compellingly, RNA interference (RNAi) silencing of ACP,
a key component of type II systems, has no effect on FA
synthesis in the cell-free system (Figure 1A). For these
and other reasons we concluded that the type II pathway
is mitochondrial and that its products are produced at low
levels. Therefore, bulk FA synthesis in trypanosomesmust
be unconventional, involving neither a type I nor a type II
FA synthase. As an alternative we considered the possibil-
ity that a microsomal FA elongase system is involved.
Elongase systems in all known cell types extend the
products of type I FA synthase (myristate in yeast and pal-
mitate [hexadecanoate; C16] in mammals) to longer-chain
FAs (Moon et al., 2001). Saccharomyces cerevisiae ELO1–
3 extendC14 to C16, C16 to C24, andC24 to C26, respec-
tively (Oh et al., 1997; Toke and Martin, 1996). The chem-
istry of the elongase reactions (diagrammed in Figure 2)
Figure 1. Effect of RNAi on Fatty Acid Synthesis and ELO3
Localization
(A) Upper panel shows effect of ACP RNAi for 2 days on cell-free FA
synthesis from butyryl-CoA in PCF trypanosomes (1.33 108 cell equiv-
alents/lane). RNAi (+), uninduced control (). Middle panel is Northern
blot showing effect of RNAi on ACP mRNA (0.9 kb). Load control
(load) is ethidium-stained rRNA. fa, free fatty acid products; PL, phos-
pholipids; o, origin.
(B) Same as (A) except ELO1 RNAi was for 4 days (1.23 107 cell equiv-
alents/lane). No lysate (nl) reaction does not contain cell membranes.
ELO1 mRNA is 2.0 kb.
(C) Same as (A) except ELO3 RNAi was for 2 days. Left panel shows
free FA products (3.5 3 107 cell equivalents/lane) using membranes
from uninduced () and RNAi-induced (+) cells. Right panel is Northern
blot showing effect of RNAi on ELO3mRNA (2.1 kb) and load control.
(D) Upper panels show fluorescence of live PCF trypanosomes ex-
pressing a C-terminal GFP-tagged ELO3. Lower panels show fluores-
cence of ER Tracker in the same cells. ELO3-GFP and ER Tracker co-
localize to the perinuclear ring (color merge not shown). All cells were
stained with ER Tracker, while ELO3-GFP expression was detected
only in a small fraction of cells.692 Cell 126, 691–699, August 25, 2006 ª2006 Elsevier Inc.resembles that of type I and type II systems, except the
growing acyl chain is esterified to CoA instead of ACP.
The ELOs condense malonyl-CoA with the growing acyl
chain, extending it by two carbon atoms (Figure 2, step
1). The resulting b-ketoacyl-CoA is then reduced (b-
ketoacyl-CoA reductase, step 2), dehydrated (b-hydrox-
yacyl-CoA dehydrase, step 3), and reduced again (trans-
2-enoyl-CoA reductase, step 4), producing a longer,
saturated acyl-CoA (Leonard et al., 2004). The two reduc-
tion steps require NADPH. We now describe the trypano-
some’s unusual biochemical machinery involving FA elon-
gases for bulk FA synthesis.
RESULTS
Elongases Are Required for Bulk Fatty
Acid Synthesis
T. brucei has four candidate ELO genes. ELO1–3 are
in tandem on chromosome seven (NCBI AAX70671,
AAX70672, and AAX70673) while ELO4 is on chromosome
five (with allelic variants AAX69821 and AAX70768). Like
S. cerevisiae ELOs, the trypanosome ELOs have multiple
predicted transmembrane domains and an HXXHH amino
acid motif (Oh et al., 1997). We used RNAi to silence ELO1
in PCF trypanosomes and then assayed membrane iso-
lates for FA synthesis. In contrast to the effect of ACP
RNAi, ELO1 knockdown drastically reduced FA synthesis
(Figure 1B). RNAi also provided preliminary evidence
that other ELOs act on longer acyl chains (Figure 1C).
These studies indicated that the ELO pathway is involved
in cell-free FA synthesis. To confirm the predicted intra-
cellular localization of one of the enzymes in this path-
way, we expressed ELO3 tagged with a C-terminal GFP;
fluorescence microscopy showed that it colocalized with
ER Tracker predominantly in the perinuclear region
Figure 2. Fatty Acid Elongation Enzyme Reactions
In step 1, b-ketoacyl-CoA synthase (elongase) condenses a long-chain
acyl-CoA (where the number ‘n’ is an even number) with two carbons
from malonyl-CoA to form b-ketoacyl-CoA. In step 2, b-ketoacyl-CoA
reductase reduces b-ketoacyl-CoA to b-hydroxyacyl-CoA, which in
turn is dehydrated in step 3 by b-hydroxyacyl-CoA dehydrase. The re-
sulting enoyl-CoA is reduced by trans-2-enoyl-CoA reductase in step 4
to produce a saturated acyl-CoA chain. NADPH is required for steps 2
and 4.
(Figure 1D), similar to the localization of the yeast ELO
pathway (Kohlwein et al., 2001).
Sequential Fatty Acid Synthesis by ELO1–3
To evaluate more rigorously the role of each ELO in FA
synthesis, we made knockout strains for each of the four
ELO genes (Delo) in BSF trypanosomes. Figure 3 shows
Southern blots confirming the knockout of each gene.
We assayed membranes from wild-type and knockout
strains in the cell-free FA synthesis system (Morita et al.,
2000) using acyl-CoA primers of varying chain length.
We detected and quantitated the products by thin layer
chromatography (TLC) and phosphorimaging (Figure 4A),
and we determined the product chain lengths by reverse-
phase TLC of their methyl esters (Figure 5A). These data
(presented below) show that ELO1 mainly extends C4 to
C10, ELO2 extends C10 to C14, and ELO3 extends C14
to C18. Furthermore, the ELO specificities are overlap-
ping. For example, ELO2, which prefers C10- and C12-
CoA primers, also has low activity with C8- and C14-CoA.
Using wild-type membranes, we found robust synthesis
with primer lengths from four to 12 carbons, though utiliza-
tion of C4- and C12-CoA primers was about half as ef-
ficient as that of the intermediate primers (Figure 4A).
Wild-type membranes showed relatively low extension
of C14- and C16-CoA, as expected, because BSFsmainly
synthesize C14 (Morita et al., 2000). Chain-length analysis
of the FA products from these wild-type reactions re-
vealed that C4-CoA is elongated efficiently, mostly to
C14, with little accumulation of intermediates (Figure 5A).
In contrast, elongation of C6- and C8-CoA appeared less
processive, with more accumulation of intermediates. Ar-
gentation TLC, a procedure that fractionates FAs by de-
gree of unsaturation, revealed small amounts of unsatu-
rated FAs (Figure 5B); these are likely due to the activity
of desaturases on the products of the ELO pathway.
In Delo1 membranes, synthesis from primers ranging
fromC4- toC12-CoAwasalmost completely lost, whereas
synthesis from C14- and C16-CoA was less affected (Fig-
ure 4A). Despite these observations, other evidence indi-
cates that ELO1 is mainly involved in synthesis up to
Figure 3. Southern Analysis of BSF ELO1–4 Genomic Knock-
outs (Delo)
Genomic DNA from wild-type (wt), heterozygous (+/), and homozy-
gous knockout clones (Delo) was restriction digested with MluI/NotI/
XhoI, NdeI/SacI/XhoI, KpnI/PacI/SacI, and MluI/NotI/XhoI, respec-
tively, for ELO1–4 blots. Fragments were detected with appropriate
probes. ACP 50 UTR sequence was used to control for loading
(load). Wild-type sample for ELO3 was lost.C10. As shown in Figures 4A and 5A, BSF Delo2 mem-
branes efficiently utilize primers up to C8 (forming C10),
an activity that must be due to ELO1. Furthermore, cerule-
nin does not affect synthesis in the cell-free system up to
C10, but blocks further elongation (Morita et al., 2000),
suggesting that it inhibits ELO2, but not ELO1. We do
not know the reason why BSF Delo1 is defective in
ELO2 activity; perhaps ELO1 protein is required for down-
stream ELO activity in vitro.
We used the same approach to study the specificities
of ELO2–4. Membranes from Delo2 were mainly deficient
in extending C10- and C12-CoA primers (Figure 4A).
As mentioned, chain-length analysis of these products
showed that Delo2 stops FA synthesis at C10 with
shorter primers (Figure 5A). The minor chain elongation
of C10- and C12-CoA in Delo2membranes is likely due to
overlapping ELO1 and ELO3 activities. Similarly, Delo3
membranes appeared deficient in extending C14- and
C16-CoA and chain elongation of shorter primers stopped
at C14 (Figures 4A and 5A). The chain-length specificity
of ELO3 was confirmed using PCF ELO3 RNAi mem-
branes (Figure 1C). Residual elongation of C14-CoA in
Figure 4. Fatty Acid Synthesis by BSF Delo1–4 Membranes
from Various acyl-CoA Primers
(A) The segment of the TLC plate with free FAs is shown (1.83 107 cell
equivalents/lane). The minor upper component is neutral lipid (e.g., tri-
glyceride). Protein per lane ranged from 7.5 to 10.3 mg. The no primer
control for Delo3 is from a duplicate experiment. Phosphorimager
quantitations of FAs are indicated in arbitrary units (au) for wild-type
and as a percentage of wild-type for the knockouts (% wt).
(B) Similar to (A) except 1.33 107 cell equivalents were loaded per lane
and protein was 22 and 15 mg/lane for wild-type and Delo4, respec-
tively. C18-CoA primer was included to control for Delo4 membrane
activity; the low level of product corresponds to C20 (S.H.L., unpub-
lished data), which is probably due to overlapping ELO3 activity.Cell 126, 691–699, August 25, 2006 ª2006 Elsevier Inc. 693
Figure 5. Analysis of Chain Length and
Unsaturation of Fatty Acid Synthesis
Products
(A) FA methyl esters (5000 DPM/lane when
available) were fractionated on reverse-phase
TLC. Thus, intensities are not proportional to
products formed. The uppermost band is an
aqueous phase contaminant that increases
with volume of hexane phase loaded. The
band labeled with (*) in the C16-CoA panel is
C18:1. We have not characterized the faint lad-
der of C8 to C18 products observed in Delo2
and Delo3 lanes (C16-CoA primer) and that is
sometimes observed in no primer samples.
(B) Argentation TLC of methyl esters of prod-
ucts from wild-type C6-CoA (6) and C16-CoA
(16) primed FA synthesis reactions. Origin, o;
saturated species, 0; mono-unsaturated, 1;
di-unsaturated, 2; tri-unsaturated, 3; and tetra-
unsaturated species, 4.
(C) Substrate preferences for ELO1–3.Delo3membranes is likely due to overlapping ELO2 activ-
ity. Substrate preferences for ELO1–3 are summarized
in Figure 5C. Taken together, these data indicate that
ELO1–3 account for virtually all of the FA synthesis ob-
served in the cell-free system.
ELO4 Elongates Arachidonoyl-CoA
Using primers up toC16-CoA, the products ofDelo4mem-
branes resembled those of wild-type, indicating ELO4 is
not involved in FA synthesis up to C18 (Figures 4A and
5A). However, ELO4 elongates the unsaturated long chain
FA arachidonate (C20:4 or 5,8,11,14-eicosatetraenoate).
Although wild-type membranes efficiently elongated
arachidonoyl-CoA (Figure 4B) and chain-length analysis
revealed a single radiolabeled product that coeluted with
C22:4 (S.H.L., unpublished data), Delo4membranes were
inactive in this reaction.
Fatty Acid Synthesis in Cultured Parasites
We next tested whether the ELO pathway is responsible
for FA synthesis in cultured T. brucei.We identified a single
gene for enoyl-CoA reductase (EnCR; NCBI AAX80213) on
chromosome three by homology to that from S. cerevi-
siae, where it functions downstream of all three yeast
ELOs (Kohlwein et al., 2001). We found EnCR RNAi cells
defective for growth in both low-lipid (Figure 6A) and, to
a lesser extent, normal media (S.H.L., unpublished data),
indicating that the ELO pathway is essential in PCF try-
panosomes. The growth defect was reversed by stearate
addition (Figure 6A). This rescue, signifying that inade-
quate stearate is produced in the RNAi cells, demon-
strates that the ELO pathway is involved in stearate syn-
thesis in cultured T. brucei. We then assayed RNAi
membranes for cell-free FA synthesis and found 77%,
63%, and 54% reduced activity, compared to uninduced
control, using C4-, C10-, and C14-CoA primers, respec-
tively (Figure 6B). As with many other trypanosome genes,
EnCR RNAi was incomplete. Based on the RNAi pheno-
type, it is likely, as in yeast, that ELO1–3 share a single694 Cell 126, 691–699, August 25, 2006 ª2006 Elsevier Inc.EnCR. Finally, we measured the effect of EnCR RNAi on
FA synthesis in cultured parasites. Since trypanosomes
do not take up [14C]acetate (Morita et al., 2000), an FA pre-
cursor, we radiolabeled them with [14C]threonine, which is
catabolized to glycine and acetyl-CoA (vanWeelden et al.,
2005). The latter compound is incorporated into FAs fol-
lowing conversion to malonyl-CoA (Klein and Linstead,
1976; van Weelden et al., 2005). We detected all FA syn-
thesis intermediates between C8 and C18 (C6 methyl
ester is lost during the hexane extraction), which indi-
cates that the whole pathway is active in the parasite
(Figure 6C). Because [14C]threonine labeling of FAs from
C8 to C18 is reduced by 48% in normal and 68% in low-
lipid medium by EnCR RNAi (Figure 6C, lanes 1 and 2 or
3 and 4), and because RNAi was likely incomplete, the
ELO pathway must be responsible at least for the majority
of FA synthesis in cultured T. brucei.
Regulation of the ELO Pathway
It appears that the T. brucei ELO pathway is regulated.
Comparison of lanes 1 and 3 in Figure 6C (both uninduced
for RNAi) shows that PCF FA synthesis is increased 98%
following growth in low-lipid medium, indicating that the
entire ELO pathway is upregulated in a low-lipid environ-
ment. In a control experiment, we found that [14C]threo-
nine was taken up at a 38% lower rate (average of three
time points up to 4.5 hr) by cells grown in low-lipid medium
than by those grown in normal medium. Therefore, the
higher rate of incorporation of 14C into FAs in low-lipid
medium is not due to higher uptake of the [14C]threonine
precursor.
Fatty Acid Synthesis in Other Trypanosomatids
The genomes of related disease-causing trypanosoma-
tids Leishmaniamajor and Trypanosoma cruzi also encode
ELO systems. Indeed, like T. brucei, their membranes
efficiently synthesize FAs from butyryl-CoA but not ace-
tyl-CoA (Figure 7). Although in vitro synthesis activity
was more robust in T. cruzi than in L. major, FA synthesis
products ranging from C8 to C18 were observed in both
systems.
DISCUSSION
A New and Versatile Pathway for Fatty
Acid Synthesis
African trypanosomes use an unprecedented mechanism
to synthesize FAs. All other cell types, whether prokaryotic
or eukaryotic, utilize conventional type I or type II FA syn-
thases. T. brucei is the first example of a cell that has
adapted microsomal elongases for bulk FA synthesis.
We have also presented evidence that two related para-
sites, L. major and T. cruzi, utilize elongases for FA synthe-
sis. Whereas the T. brucei genome encodes four ELOs,
L.major and T. cruzi genomes encode 13 and five, respec-
tively. As with T. brucei, the genomes of these related par-
asites also encode a type II FA synthase, but not a type I.
We have found in T. brucei that components of the type II
system localize to the mitochondrial matrix (K.P. and
Figure 6. Effect of RNAi Knockdown of Enoyl-CoA Reductase
in PCFs
(A) Growth of cells in low-lipid medium in the presence or absence of
35 mM stearate. Uninduced control, no stearate (closed circles);
RNAi, no stearate (closed diamonds); uninduced control plus stearate
(open triangles); RNAi plus stearate (open squares). Inset is Northern
blot showing reduced enoyl-CoA Reductase (EnCR) mRNA (3.1 kb)
after 6 days of RNAi. Load control (load) is ethidium-stained rRNA.
(B) Portion of TLC showing free FA products formed in 10 min with C4,
C10, and C14-CoA in uninduced () and 5 day RNAi induced (+) mem-
branes (1.63 107 cells/lane). Protein per lane was 15.7 mg and 23.1 mg,
respectively.
(C) Chain-length analysis of FAs labeled with [14C]threonine after 5 (+)
or no () days of RNAi (1.53 107 cells/lane). Cells were cultured either
in normal (100%) or low-lipid (20%)medium. Lane 5 is a zero time point
labeling control.J.S., unpublished data), and the same is likely true for
L. major and T. cruzi. We also have found that FA products
of the trypanosomemitochondrial system are produced at
a very low level (J.S., unpublished data). Therefore, nearly
all of the FAs synthesized in T. brucei are produced by the
elongase pathway.
Why do these parasites utilize the elongase pathway for
FA synthesis? One obvious advantage is that synthesis is
near the site of product utilization. Phospholipid synthesis
in the ER membrane can utilize FAs made nearby. Also,
GPImyristoylation, which occurs in the ERof BSF trypano-
somes, can employ myristate, a major product of the ELO
pathway. Another advantage is that the stepwise synthesis
of FAs to C10, C14, and finally to C18 allows convenient
switching of the products of the pathway. The obvious
example is in BSF T. brucei where selective downregula-
tion of ELO3 (see below) results in synthesis of myristate.
We speculate that some of the 13 ELOs in L. major are
specialized for synthesis of the long-chain fatty acyl
groups and synthesis of the carbon chains of the alkyl
groups needed for both glycoinositolphospholipids and
the GPI anchors of promastigote surface protease and
lipophosphoglycan (Ferguson, 1997).
Regulation of the ELO Pathway
The versatility of the ELO pathway is enhanced by the fact
that it can be regulated to suit the parasite’s needs. We
Figure 7. Cell-Free Fatty Acid Synthesis in T. cruzi Epimasti-
gotes and L. major Promastigotes
FA synthesis reactions using acyl-CoA primers ranging from C2 to C14
were conducted essentially as with T. brucei (see Experimental Proce-
dures). Activity in the no primer lane (no) is likely due to endogenous
primers. Upper panel is a TLC analysis, while lower panels show chain
lengths of products. fa, free fatty acid products; PL, phospholipids; o,
origin. Unsaturated FA products such as C18:1 and C18:2 coelute with
C16:0 and C14:0, respectively. For all panels, 1.3 3 107 cell equiva-
lents/lane were loaded.Cell 126, 691–699, August 25, 2006 ª2006 Elsevier Inc. 695
found in PCFs that the entire pathway is upregulated when
the cells are cultured in low-lipid medium (Figure 6C).
There are also previously published observations that
can now be explained in terms of regulation of the ELO
pathway. These include the facts that the rate of FA syn-
thesis in PCFs, as measured in the cell-free system, is
5.3-fold higher than in BSFs, indicating upregulation of
the pathway in PCFs (Morita et al., 2000). Also, the differ-
ent FA products produced in BSFs and PCFs can be ex-
plained by selective up- or downregulation of ELO3 (Mo-
rita et al., 2000). Another example comes from our previous
report that BSFs grown in medium containing 5% serum
efficiently elongate exogenous [3H]myristate to palmitate
and stearate, whereas trypanosomes in whole blood
do not (Doering et al., 1993). Whole blood has 20 times
more palmitate and stearate than media with 5% serum.
Therefore, BSF ELO3 must be downregulated during
culture in whole blood and upregulated during growth in
FA-depleted medium. These findings indicate that try-
panosomes regulate FA synthesis by the ELO pathway in
response to environmental FAs. We do not yet know the
molecular mechanisms by which they sense the level of
exogenous FAs and possibly even distinguish among
exogenous FAs that differ in chain length. We also do
not know the mechanism of regulation of the pathway; in
S. cerevisiae the level of ELO mRNA depends on the con-
centration of exogenous FAs (Toke and Martin, 1996).
Thus, the elongase pathway is ideally suited for para-
sites that migrate between vector and host and from one
compartment to anotherwithin the vector or host. Depend-
ing upon the needs of a life-cycle stage and the availability
of exogenous FAs, the ELO pathway can readily adapt to
produce different products at the appropriate concentra-
tion. For example, we speculate that when BSFs invade
the cerebrospinal fluid, where the ratio of total lipids to
that in serum is 0.003 (Lentner, 1981), the ELO pathway
would be upregulated to produce not only myristate for
GPI anchors, but also longer FAs for phospholipids.
Is the ELO Pathway Essential?
There are still unanswered questions concerning the ELO
pathway. One critical question is whether the pathway is
essential for growth of BSFs and therefore a candidate
drug target. ELOs are clearly essential for PCF trypano-
somes. RNAi silencing of EnCR, an enzyme in the ELO
pathway, causes growth arrest, but normal growth is re-
stored when the culture is supplemented with stearate.
In the case of BSFs, ELO knockout lines grew normally
in culture and were competent for infection in rats, sug-
gesting that the pathway may not be required for growth
in lipid-rich environments. However, it is possible that
ELO specificities overlap sufficiently to compensate for
knockout of a single ELO; another possibility is that the
pathway is essential only in lipid-poor environments.
Substrates for Fatty Acid Synthesis
Although we know the origin of most of the substrates for
the ELO pathway, the source of the butyryl-CoA primer is696 Cell 126, 691–699, August 25, 2006 ª2006 Elsevier Inc.not yet known. The malonyl-CoA is formed by an acetyl-
CoA carboxylase, probably in the cytosol, and NADPH
can be produced either by oxidation of malate to pyruvate
by a cytosolic malic enzyme (van Weelden et al., 2005) or
by the pentose phosphate shunt, which may be localized
in both the cytosol and the glycosomes (Duffieux et al.,
2000). It is important to note that the ELO3 component
of the pathway can act as a conventional ELO system,
elongating exogenously supplied myristate to palmitate
and stearate (Doering et al., 1993). In addition, ELO4 acts
as a conventional polyunsaturated FA elongase in that it
elongates arachidonoyl-CoA (C20:4) to C22:4.
It is striking that cell-free FA synthesis utilizing wild-type
BSF membranes and a butyryl-CoA primer appears proc-
essive. Under these conditions, there are only low concen-
trations of intermediates detected, and the major product
is C14 (Figure 5A, second panel). It is possible that when
the entire pathway is operational, starting with butyryl-
CoA, growing acyl-CoAs are channeled, with no release
of intermediates. In contrast, use of C6- and C8-CoA
primers (Figure 5A, third and fourth panels), results in non-
processive synthesis of C14, with detection of all interme-
diates. The mechanistic explanation for these differences
is not known, but a similar situation occurs in yeast (Dit-
trich et al., 1998). Substrate channeling might not only in-
crease the efficiency of FA synthesis, but it also could im-
pact GPI myristoylation. We found previously that the GPI
remodeling enzymes in vitro can utilize FAs shorter than
myristate; among shorter acyl chains, lauroyl-CoA and oc-
tanoyl-CoA are the preferred substrates (Morita and En-
glund, 2001). Myristate specificity in remodeling was pre-
viously assumed to be due to the lack of other available
short-chain fatty acyl-CoAs. However, we now know that
these other substrates (octanoyl-CoA to lauroyl-CoA) are
present in the cell as intermediates in the FA synthesis
pathway. Substrate channeling through the ELO pathway
could prevent their incorporation into GPIs.
Conclusion
T. brucei and its trypanosomatid kin are unique among eu-
karyotes in that they synthesize FAs with a microsomal
elongase pathway that is distinct from conventional type
I and II synthases. This mechanism is a third type of FA
synthesis. It is likely that the parasite’s need for rapid
adaptation to diverse host environments had a hand in
the evolution of this piecemeal FA synthesis pathway.
EXPERIMENTAL PROCEDURES
Trypanosomes
Procyclic T. brucei brucei strain 29-13 (Wirtz et al., 1999) and derived
cells were cultured at 27C and 5%CO2 in SDM-79 medium (Brun and
Schonenberger, 1979). Bloodstream wild-type 427, 90-13, and knock-
out strains were cultured at 37C and 5% CO2 in HMI-9 medium
(Hirumi and Hirumi, 1989). BSF lysates were made from trypanosomes
grown in rats. Strain 90-13 was grown in nonirradiated retired male
breeder rats while Delo1–4 strains were grown in lethally irradiated
(1000 rad) rats. Trypanosomeswere harvested by cardiac exsanguina-
tion when parasitemias reached 1–2 3 109 trypanosomes/ml. Blood
was transferred to an equal volume of Percoll (Sigma) containing
67 U/ml heparin, 8.6% sucrose, and 2.0% glucose (pH adjusted to
7.5 with solid HEPES) (Grab and Bwayo, 1982). After centrifugation
(28,000 3 g, 4C, 15 min), the upper layer of trypanosomes was puri-
fied further by DE53 chromatography (Lanham and Godfrey, 1970).
BSF and PCF crude cell membranes were prepared by washing cells
in BBSG (50 mM bicine-Na [pH 7.5], 50 mM NaCl, 5 mM KCl, and
70 mM glucose). Cells (109/ml) were osmotically lysed on ice in
1 mM HEPES-KOH [pH 7.5], 1 mM EDTA, 1 mg/ml leupeptin, and
0.1 mM TLCK. After 5 min, an equal volume of 100 mM HEPES-KOH
[pH 7.5], 50 mM KCl, 10 mMMgCl2, 300 mM sucrose, 1 mg/ml leupep-
tin, and 0.1 mM TLCK was added. Lysate aliquots were snap-frozen
and stored at 80C.
RNAi
A fragment from a region of the target open reading frame was cloned
into pZJM, a vector for tetracycline-inducible RNAi (Wang et al., 2000).
For ACP, the pZJM insert was 447 bp encoding the entire open reading
frame. The ELO1 insert was 571 bp, starting with 50 TTGCCAATAA;
ELO3 insert was 415 bp, starting with 50 ACACGGCCTT; and that for
EnCR was 416 bp, starting with 50 GGAGCTGGAG. pZJM transform-
ants of T. brucei 29-13 were selected and cloned by limiting dilution.
RNAi induction and Northern analyses were performed as described
(Wang et al., 2000).
Intracellular Localization
The ELO3 gene product was GFP-tagged at its C terminus. Its gene
sequence was PCR amplified with 50-MluI-HindIII-XbaI-ATGTTGATG
AACTTCGGGGGCTCCT-30 forward primer and 50-BamHI-NheI-XhoI-
TTTCTTTATTTCCGCTGCTACGTGTGGA-30 reverse primer and in-
serted into the HindIII and NheI restriction sites of the pXSGFPM3FUS
vector (Marchetti et al., 2000) for constitutive expression. The
pXSGFPM3FUS NEO marker was also replaced with blasticidin drug
marker using flanking AscI and PacI restriction sites. The vector was
linearized with MluI for integration into the tubulin gene locus of wild-
type 427 PCF trypanosomes. Transformants were selected with
10 mg/ml blasticidin. To stain ER, cells were incubated 30 min at
27C and 5% CO2 with 0.5 mM ER tracker Blue-White DPX (Molecular
Probes) in BBSG.
Generating ELO Knockouts and Southern Analysis
ELOgenes inBSF427strainwere replacedbyhomologous recombina-
tion with pKONEO and pKOHYG cassettes containing 500 bp each of
50 and 30 sequences surrounding the open reading frame of the target
gene (Lamb et al., 2001). Knockout transformants were cloned and
drug selection was removed after gene deletions were confirmed by
Southern analysis. For the latter, genomic DNA was isolated using
Puregene DNA isolation kit (Gentra Systems), restriction digested,
and fractionated. DNA was partially depurinated, transferred to
GeneScreen Plus Nylon membrane (Perkin Elmer), and hybridized
at 40C to digoxigenin-labeled ELO gene sequences according to
instructions in the DIG Probe Synthesis Kit and DIG Easy Hyb Kit
(both from Roche).
Cell-Free Fatty Acid Synthesis
Thawed cell lysates were washed twice in HKML buffer (50 mM
HEPES-KOH [pH 7.4], 25 mM KCl, 5 mM MgCl2, 1 mg/ml leupeptin)
and protein concentration was determined by the Bradford assay (Bio-
Rad). Duplicate FA synthesis assays were conducted at 1 3 109 cell
equivalents/ml in HKML, 1 mM DTT, 2 mM each of NADPH and
NADH, 50 mM [2-14C]malonyl-CoA (American RadiolabeledChemicals,
55 mCi/mmol), and 50 mM acyl-CoA primer. Incubations were at 37C
for 30 min unless otherwise indicated. Lipids were extracted and
fractionated on silica gel 60 HPTLC plates (EMD Chemicals Inc.) and
visualized on Kodak BioMax MR film (Morita et al., 2000). Free FAs
on TLC plates were quantitated using a Fujifilm BAS-2500 Phosphor-
imager. FA synthesis, measured as photostimulated luminescence,was corrected for local background and normalized for protein con-
centration. For the experiment in Figure 4B, lysates were washed
once in HKML buffer, NADH was omitted, and 25 mM [2-14C]-
malonyl-CoA was used.
Fatty Acid Chain-Length Analysis
Chloroform/methanol/water (CMW) 10:10:3 extracts from cell-free FA
synthesis reactions (2.0 3 107 cell equivalents) or 3H-labeled FA
standards were mixed with carrier FAs (0.2 nmol each of C8, C10,
C12, C14, and C16). Samples were dried under N2 gas, dissolved in
0.1 ml dry methanol containing 2% H2SO4 and 0.2% benzene, and in-
cubated at 65C for 2–16 hr to form methyl esters. Reactions were
stopped with 100 ml water and FA methyl esters were extracted with
100 ml hexane (Fosbrooke and Tamir, 1968). Methyl esters of shorter
fatty acids, especially C6, are lost during the hexane extraction. The
hexane extracts were fractionated on C18 RP-TLC plates (Analtech)
using CMW 5:15:1 v/v as mobile phase.
Argentation TLC
Silver nitrate (Sigma; 1.5 g) was dissolved in 12 ml of 50% acetonitrile
and sprayed onto a 10 cm 3 10 cm silica gel 60 plate using an atom-
izer. After drying in the hood, the plate was baked 30 min at 95C.
Methyl esters of C18:1, C18:2, C18:3, and C20:4 were used as stan-
dards and in a carrier mix (3.8% each of 16:1, 18:2, 18:3, and 20:4
methyl esters and 5% 18:1 methyl ester in hexane) that was spotted
on the radiolabeled samples at the origin (1 ml/lane). The TLC
was run 8 cm in dichloromethane. Standards were visualized by incu-
bating the dried plate in a chamber equilibrated with iodine crystals.
The plate was then sprayed with En3Hance (NEN), dried, and visual-
ized on film.
Measurement of Fatty Acid Synthesis in Cultured Parasites
Cells were grown either in normal medium (SDM-79 containing 10%
FBS) or in low-lipid medium (SDM-79 supplemented with 10% delipi-
dated FBS from Cocalico Biologicals). The latter medium contains
20% of the lipids of normal medium. Stearate (35 mM) with a-cyclo-
dextrin (350 mM) as carrier was delivered andRNAi was induced on day
zero. Prior to metabolic labeling, cells were maintained in either normal
medium or in low-lipid medium. After 5 days, cells (3–53 106/ml) were
washed and resuspended at 1.23 108 cells/ml in delipidated FBS con-
taining appropriate drugs. Cells (63 107) were then treatedwith 1.2 mCi
L-[UL-14C]threonine (Sigma, 155mCi/mmol) for 4.3 hr (27C, 5%CO2).
Cellswere centrifuged,washedwith PBS, and extracted in 0.8mlCMW
10:10:3. Part of the CMW phase (1.5 3 107 cell equivalents) was used
for chain-length analysis. Cells had normal morphology and motility
after radiolabeling.
[14C]Threonine Uptake
Procyclic T. brucei grown 5 days in normal or low-lipid medium were
washed twice in BBSG and resuspended at 1.2 3 108 cells/ml in deli-
pidated FBS containing appropriate drugs. Samples (350 ml) were
treated with [14C]threonine and incubated at 27C under 5% CO2. At
times up to 4.5 hr, 50 or 100 ml aliquots were layered onto a mixture
of 95 ml of dibutyl phthalate and 5 ml of paraffin oil, and cells were centri-
fuged through the oil mixture in a microfuge (Parsons and Nielsen,
1990). The upper aqueous phase was removed and the tube contain-
ing the remaining oil and cells was washed twice with 100 ml PBS. The
oil mixture was then removed, and the cell pellet was washed with
fresh oil mixture. Cells were resuspended in PBS, transferred to scin-
tillation fluid, and counted.
Fatty Acid Synthesis in T. cruzi and L. major
T. cruzi CL Brener epimastigotes were grown in LIT medium supple-
mented with 10% FBS at 27C (Zingales et al., 1997). L. major Friedlin
promastigotes were grown in chemically defined M199+ medium (Mc-
Carthy-Burke et al., 1991) supplemented with 2 mM glutamine (Gibco)
and 0.1mM adenosine (Sigma) at 26C.Membranes were prepared byCell 126, 691–699, August 25, 2006 ª2006 Elsevier Inc. 697
the method used for T. brucei, except L. majorwas lysed in double the
volume of lysis buffer; thus lysates were half as concentratedwhen fro-
zen. Cell-free FA synthesis assays were performed as before with
NADPH as reducing agent (NADH was omitted). For FA chain-length
analyses, carrier FAs were omitted.
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